TY - JOUR
T1 - Expression of the c-myc, c-fos and c-rasHa protooncogenes during sex-differentiated rat liver carcinogenesis in the resistant hepatocyte model
AU - Porsch-hällström, Inger
AU - Blanck, Agneta
AU - Eriksson, Lennart C.
AU - Gustafsson, Jan Åke
N1 - Funding Information:
This work was supported by grants from the National Cancer Institue (1 RO1 CA42, 054-01Al), the Swedish Cancer Society, The Cancer Society in Stockholm and the Research Funds of the Karolinska Institute.
PY - 1989/10
Y1 - 1989/10
N2 - The expression of the protooncogenes c-myc, c-los and c-rasHa has been studied in rats treated according to the resistant hepatocyte model. Protooncogene expression was studied in male and female rat liver during the selection phase, when the outgrowth of putative preneoplastic foci/nodules is markedly faster in males, and compared with the expression in advanced nodules and hepatocellular carcinomas in males. During the first 16 h after partial hepatectomy the expression of c-los and c-myc showed transient, 2- to 3-fold, increases in both sexes, both in initiated and in 'control' animals, receiving the selection/promotion regimen but no diethyl nitrosamine, with a maximum at 0.5 and 2-4 h respectively. c-rasHa exhibited a moderate increase (1.5-fold) at 16-24 h in all groups. A second increase in c-myc expression (2-fold) started 24 h after partial hepatectomy and lasted over the entire selection period in initiated males, while it was unchanged in females and uninitiated males. The c-fos expression also showed a short-lived increase 24 h post partial hepatectomy in initiated males. The expression of c-myc and c-los was increased 2- to 4-fold in both preneoplastic nodules and hepatocellular carcinomas, whereas c-rasHa expression was unchanged. In conclusion, sex differences were observed in the expression of c-myc and c-los during the early outgrowth of preneoplastic lesions, possibly reflecting a connection between the expression of these genes and the sex differentiated response to promotion in the resistant hepatocyte model. Furthermore, an overexpression also in later stages of liver carcinogenesls might indicate that expression of the protooncogenes in question is related to the entire process of multistep carcinogenesis in this model.
AB - The expression of the protooncogenes c-myc, c-los and c-rasHa has been studied in rats treated according to the resistant hepatocyte model. Protooncogene expression was studied in male and female rat liver during the selection phase, when the outgrowth of putative preneoplastic foci/nodules is markedly faster in males, and compared with the expression in advanced nodules and hepatocellular carcinomas in males. During the first 16 h after partial hepatectomy the expression of c-los and c-myc showed transient, 2- to 3-fold, increases in both sexes, both in initiated and in 'control' animals, receiving the selection/promotion regimen but no diethyl nitrosamine, with a maximum at 0.5 and 2-4 h respectively. c-rasHa exhibited a moderate increase (1.5-fold) at 16-24 h in all groups. A second increase in c-myc expression (2-fold) started 24 h after partial hepatectomy and lasted over the entire selection period in initiated males, while it was unchanged in females and uninitiated males. The c-fos expression also showed a short-lived increase 24 h post partial hepatectomy in initiated males. The expression of c-myc and c-los was increased 2- to 4-fold in both preneoplastic nodules and hepatocellular carcinomas, whereas c-rasHa expression was unchanged. In conclusion, sex differences were observed in the expression of c-myc and c-los during the early outgrowth of preneoplastic lesions, possibly reflecting a connection between the expression of these genes and the sex differentiated response to promotion in the resistant hepatocyte model. Furthermore, an overexpression also in later stages of liver carcinogenesls might indicate that expression of the protooncogenes in question is related to the entire process of multistep carcinogenesis in this model.
UR - http://www.scopus.com/inward/record.url?scp=0024743193&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024743193&partnerID=8YFLogxK
U2 - 10.1093/carcin/10.10.1793
DO - 10.1093/carcin/10.10.1793
M3 - Article
C2 - 2507186
AN - SCOPUS:0024743193
SN - 0143-3334
VL - 10
SP - 1793
EP - 1800
JO - Carcinogenesis
JF - Carcinogenesis
IS - 10
ER -